Letter to the Editor
- 1 October 2003
- journal article
- other
- Published by SAGE Publications in Lupus
- Vol. 12 (10) , 798-800
- https://doi.org/10.1191/0961203303lu450xx
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- An open study of B lymphocyte depletion in systemic lupus erythematosusArthritis & Rheumatism, 2002
- Rituximab for idiopathic membranous nephropathyThe Lancet, 2002
- Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpuraBlood, 2002
- Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximabBone Marrow Transplantation, 2002
- Anti‐CD20 monoclonal antibody (Rituximab) for life‐threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosusBritish Journal of Haematology, 2002
- Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapyArthritis & Rheumatism, 2001
- Treatment of childhood autoimmune haemolytic anaemia with rituximabThe Lancet, 2001
- Favourable response to therapy with the anti‐CD20 monoclonal antibody rituximab in primary chronic cold agglutinin diseaseBritish Journal of Haematology, 2001
- Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpuraBlood, 2001
- Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20Blood, 1994